Organic compounds

Details for Australian Patent Application No. 2007265190 (hide)

Owner Novartis AG

Inventors Shultz, Michael

Agent Davies Collison Cave

Pub. Number AU-A-2007265190

PCT Pub. Number WO2008/002862

Priority 60/816,459 26.06.06 US

Filing date 25 June 2007

Wipo publication date 3 January 2008

International Classifications

A61K 31/00 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2008/002862 Priority application(s): WO2008/002862

8 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007265215-Adhering graphic films on irregular substrates

2007265181-Phenylacetic acid derivatives as COX-2 inhibitors